Cong Minh Truong

Nhà nghiên cứu Hồ sơ 6/10

20 công bố · 29 trích dẫn · h-index 3

Thông tin

🏛️Nơi công tác: Bệnh viện Nhi Trung ương
🔬Lĩnh vực: Y - Dược
🆔ORCID: 0000-0003-3953-6729
✍️Hồ sơ chưa đầy đủ — bổ sung thông tin

Công bố tiêu biểu

Effectiveness and Tolerability of First-Line Afatinib for Advanced EGFR-Mutant Non-Small Cell Lung Cancer in Vietnam7 trích dẫn
Asian Pacific Journal of Cancer Prevention · 2021 · DOI

Treatment Outcome and Prognosis Factors of FIGO 2018 Stage III Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam6 trích dẫn
Asian Pacific Journal of Cancer Prevention · 2021 · DOI

The Effectiveness of Afatinib as First‐Line Treatment in Vietnamese Patients With EGFR‐Mutant Non–Small Cell Lung Cancer and Brain Metastases3 trích dẫn
Asia-Pacific Journal of Clinical Oncology · 2024 · DOI

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam3 trích dẫn
Therapeutic Advances in Medical Oncology · 2024 · DOI

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam3 trích dẫn
BMC Cancer · 2024 · DOI

Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study2 trích dẫn
Asian Pacific Journal of Cancer Prevention · 2024 · DOI

EMO: Embedding Model Distillation via Intra-Model Relation and Optimal Transport Alignments2 trích dẫn
· 2025 · DOI

Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam1 trích dẫn
Therapeutic Advances in Medical Oncology · 2025 · DOI

Livelihood and Environmental Impact in Urban Areas1 trích dẫn
Sustainable development goals series · 2024 · DOI

A Real-World Cohort Study of First-Line Afatinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer in Vietnam1 trích dẫn
Research Square · 2023 · DOI

Về lĩnh vực Y - Dược

6.619học giả

91.896công bố

2.589.484trích dẫn

4.2h-index trung bình

Hướng nghiên cứu phổ biến trong lĩnh vực:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Nơi có nhiều học giả lĩnh vực này nhất: